Molecule Details
| InChIKey | RHCSKNNOAZULRK-UHFFFAOYSA-N |
|---|---|
| Compound Name | Mescaline |
| Canonical SMILES | COc1cc(CCN)cc(OC)c1OC |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.25 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB19083 |
|---|---|
| Drug Name | Mescaline |
| CAS Number | 54-04-6 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Mescaline is under investigation in clinical trial NCT05933213 (Comparing Mescaline Sodium Enteric-coated Tablets vs Morte-mescaline in the Treatment of Adult Lupus Nephritis). |
Categories: Alkaloids Amines Antidepressive Agents Central Nervous System Agents Central Nervous System Depressants Ethylamines Hallucinogens Neurotransmitter Agents Phenethylamines Psychotropic Drugs Serotonin Agents Serotonin Receptor Agonists
Cross-references: BindingDB: 50059891 ChEBI: 28346 CHEMBL26687 ChemSpider: 3934 C06546 PDB: A1AFW Wikipedia: Mescaline ZINC: ZINC000000001689
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P28335 | HTR2C | Homo sapiens | Human | PF00001 | 6.5 | Ki | ChEMBL;BindingDB |
| P28223 | HTR2A | Homo sapiens | Human | PF00001 | 6.3 | Ki | ChEMBL;BindingDB |
| P18825 | ADRA2C | Homo sapiens | Human | PF00001 | 6.1 | Ki | BindingDB |
| P41595 | HTR2B | Homo sapiens | Human | PF00001 | 6.1 | Ki | ChEMBL;BindingDB |
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P28223 | HTR2A | 5-hydroxytryptamine receptor 2A | inhibitor | targets |